<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04890951</url>
  </required_header>
  <id_info>
    <org_study_id>REB19-2134</org_study_id>
    <nct_id>NCT04890951</nct_id>
  </id_info>
  <brief_title>Hysterectomy Versus Uterine Preservation for Pelvic Organ Prolapse Surgery</brief_title>
  <acronym>HUPPS</acronym>
  <official_title>Prospective Multi-site Cohort Study Investigating Hysterectomy Versus Uterine Preservation for Pelvic Organ Prolapse Surgery: The HUPPS Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Calgary</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Canadian Institutes of Health Research (CIHR)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The MSI Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Calgary</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pelvic organ prolapse (POP) is the descent of pelvic organs into the vagina resulting in&#xD;
      bulge symptoms and occurs in approximately 50% of women. Almost 20% of women will elect&#xD;
      surgical correction of this condition by age 85. Removal of the uterus (hysterectomy) with&#xD;
      concomitant vaginal vault suspension is a longstanding practice in POP surgery to address&#xD;
      apical (uterine) prolapse. Yet, contemporary evidence on the merits of this approach relative&#xD;
      to preservation of the uterus through suspension is needed to better inform surgical&#xD;
      decision-making by patients and their healthcare providers. The objective of this trial is to&#xD;
      evaluate POP-specific health outcomes and service utilization of women electing uterine&#xD;
      suspension compared to those electing hysterectomy and vaginal vault suspension for POP&#xD;
      surgery up to 1-year post-surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2020</start_date>
  <completion_date type="Anticipated">December 2024</completion_date>
  <primary_completion_date type="Anticipated">December 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Anatomic failure to correct apical POP</measure>
    <time_frame>1 year</time_frame>
    <description>Descent of the apex (POP-Q point C) equal to or beyond one half of the total vaginal length</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall failure to correct POP</measure>
    <time_frame>1 year</time_frame>
    <description>POP-Q stage ≥2 in any compartment, or re-treatment of POP with physiotherapy, pessary, or repeat surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective failure to correct POP</measure>
    <time_frame>6 weeks; 1 year</time_frame>
    <description>Patient report of bulge symptoms at 6 weeks or 1 year, using one item on the PFDI-20: &quot;Do you usually have a bulge or something falling out that you can see or feel in the vaginal area?&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of surgery (minutes)</measure>
    <time_frame>Peri-operative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimated blood loss during surgery &gt;500 mL</measure>
    <time_frame>Peri-operative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedural complications</measure>
    <time_frame>Peri-operative</time_frame>
    <description>E.g., peri-operative blood transfusion, visceral injury</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative infection</measure>
    <time_frame>Peri-operative</time_frame>
    <description>E.g., abscess, urinary tract infection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioid use in-hospital</measure>
    <time_frame>Peri-operative</time_frame>
    <description>Measured by Morphine milliequivalent (mEq)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resumption of spontaneous voiding (days)</measure>
    <time_frame>Peri-operative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of post-operative stay (days)</measure>
    <time_frame>Peri-operative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PROM: Total Pelvic Floor Impact Questionnaire-7 (PFIQ-7) score</measure>
    <time_frame>6 weeks; 1 year</time_frame>
    <description>Change from baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PROM: Total POP Incontinence Sexual Questionnaire Revised (PISQ-IR) score</measure>
    <time_frame>6 weeks; 1 year</time_frame>
    <description>Change from baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PROM: Total Pelvic Floor Distress Inventory-20 (PFDI-20) score</measure>
    <time_frame>6 weeks; 1 year</time_frame>
    <description>Change from baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presentation at the emergency department</measure>
    <time_frame>30 days (any health complaint); 1 year (pelvic floor-related complaint)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital readmission</measure>
    <time_frame>30 days (any health complaint); 1 year (pelvic floor-related complaint)</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">321</enrollment>
  <condition>Pelvic Organ Prolapse</condition>
  <arm_group>
    <arm_group_label>Uterine Preservation</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Hysterectomy</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hysteropexy</intervention_name>
    <description>Uterine preservation through suspension</description>
    <arm_group_label>Uterine Preservation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hysterectomy and vaginal vault suspension</intervention_name>
    <description>Uterine removal and sewing the vagina upwards</description>
    <arm_group_label>Hysterectomy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Women seeking surgical correction of POP at one of the study sites.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Have diagnosed POP of stage ≥2 using the globally recognized Pelvic Organ&#xD;
             Prolapse-Quantification System (POP-Q)&#xD;
&#xD;
          -  Elect surgical management of POP&#xD;
&#xD;
          -  Demonstrate presence of apical prolapse on clinical exam deemed to require either a&#xD;
             hysterectomy and concomitant vaginal vault suspension or uterine suspension to&#xD;
             properly address their POP during surgical correction&#xD;
&#xD;
          -  Desire no further pregnancy&#xD;
&#xD;
          -  Can communicate in English&#xD;
&#xD;
          -  Are ≥18 years in age&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Prior hysterectomy&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Erin A Brennand, MD</last_name>
    <phone>403-944-1636</phone>
    <email>Erin.brennand@albertahealthservices.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>Pelvic Floor Clinic</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Natalie Scime, MSc</last_name>
      <email>natalie.scime@ucalgary.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>May 5, 2021</study_first_submitted>
  <study_first_submitted_qc>May 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 18, 2021</study_first_posted>
  <last_update_submitted>May 31, 2021</last_update_submitted>
  <last_update_submitted_qc>May 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pelvic Organ Prolapse</keyword>
  <keyword>Gynecologic Surgery</keyword>
  <keyword>Female</keyword>
  <keyword>Epidemiology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Pelvic Organ Prolapse</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

